Nomura Holdings’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Nomura Holdings’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-25,000	Closed	-$340K	–	1762
2016 Q4	$340K	Buy	+25,000	New	+$349K	﹤0.01%	1323
2016 Q1	–	Sell	-13,075	Closed	-$227K	–	2235
2015 Q4	$227K	Buy	13,075 +590	+5%	+$10.6K	﹤0.01%	1514
2015 Q3	$240K	Buy	+12,485	New	+$286K	﹤0.01%	1308

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Nomura Holdings's SCMP Position: Q1 2017 in Review

Nomura Holdings sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2017, closing a stake of 25,000 shares — an estimated $340K sold.

Nomura Holdings first reported a position in SCMP in Q3 2015 and held it in 3 quarters. The position peaked at $340K in Q4 2016. 167 funds tracked by Wall St. Rank hold SCMP as of Q1 2017.

Nomura Holdings reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Nomura Holdings sold 25,000 Sucampo Pharmaceuticals, Inc. shares in Q1 2017, an estimated $340K.
Nomura Holdings first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 3 quarters.
Nomura Holdings's Sucampo Pharmaceuticals, Inc. position peaked at $340K in Q4 2016.
167 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2017.

Based on Nomura Holdings's 13F filing for Q1 2017, filed 15 May 2017.